Trials / Completed
CompletedNCT01267305
The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 362 (actual)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the use of different dose of LMWH compared with fondaparinux for thromboprophylaxis is efficacious and safety after thoracic surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fondaparinux | 2.5mg IH qd(8AM) after operation |
| DRUG | Nadroparin Calcium | 4100AxaIU IH qd(8AM) after operation |
| DRUG | Nadroparin Calcium | 4100AxaIU IH q12h(8Am,8Pm) after operation |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2013-04-01
- Completion
- 2013-08-01
- First posted
- 2010-12-28
- Last updated
- 2014-04-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01267305. Inclusion in this directory is not an endorsement.